The Global 3D Bioprinting Market experienced significant growth, with its revenue reaching approximately $1.3 billion in 2022. Projections indicate that this market is on track to expand even further, aiming to achieve a valuation of around $3.3 billion by 2027. This growth trajectory is underpinned by a robust compound annual growth rate (CAGR) of 20.8% from 2022 to 2027. Download...